SUMMARY Histopathological assessment and flow cytometric analyses were carried out on 32 placentas (representative of each trimester) and 88 molar pregnancies. Three first trimester placentas were triploid, and the remaining 29 placentas were diploid. Of the 88 cases originally diagnosed as molar pregnancies, 26 were triploid (two complete moles, 20 partial moles, and four hydropic abortions); 59 were diploid (46 complete moles, 10 partial moles, three hydropic abortions); one was tetraploid (partial mole); and two were DNA aneuploid (one partial mole, one complete mole). A significantly increased hyperdiploid fraction (a measure of cell proliferation) was detected in diploid complete moles (p < 0-0001) and cases of persistent trophoblastic disease (p < 0-001) when compared with diploid placentas and diploid partial moles. All seven cases of established persistent trophoblastic disease, for which follow up was available, were diploid and showed high hyperdiploid fractions within the range for diploid complete moles. These findings suggest that flow cytometric DNA measurements may be an important aid in the diagnosis of molar pregnancy. The high degree of cell proliferation found in this study may explain the premalignant potential of complete hydatidiform moles.
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The distinction between partial moles and complete moles and their differentiation from hydropic abortions is a recurring and common problem for histopathologists.' The use of cytogenetic techniques,2-6 morphological studies,78 and enzyme markers3-4 have been of some assistance in making these distinctions. Complete moles are diploid, usually XX (rarely Xy),9'-2 and are androgenetic in origin.2 It has been suggested that complete moles with a 46XY karyotype may be more likely to progress to persistent trophoblastic disease'2 than complete moles with a 46XX karyotype. Partial moles are usually considered to be triploid (XXX or XXY), showing fetal presence and a maternal chromosomal contribution. 5 The subdivision of molar and hydropic gestations has considerable prognostic importance. About 10% of patients with complete moles develop persistent trophoblastic disease,'3 including the entities of invasive mole and choriocarcinoma, and a mole is the preceding gestation in at least half of all cases of choriocarcinoma.14 At present, the malignant potential of partial moles is uncertain. 13 15 16 There are at least three published cases of persistent trophoblastic Accepted for publication 22 December 1986 disease"7-19 and one case of fatal metastic choriocarcinoma20 developing after the diagnosis of a putative partial mole. It has been recommended that the clinical management of partial moles should be no different from that of complete moles,"3 but this may result in unnecessary follow up of patients, which is both time consuming and expensive.
We have therefore investigated whether the identification of patients likely to progress to persistent trophoblastic disease could be assisted by flow cytometric analysis of DNA content. 
Material and methods

CASES
PLACENTAS
Twenty nine of the 61 placentas studied were unsuitable for flow cytometric analysis, probably because of poor fixation. Three of the first trimester placentas (n = 14) were triploid; the other 11 diploid placentas ,1 6 4 showed a median hyperdiploid fraction of 16-6% (Sth-95th percentiles = 6 7%-20 8%) (fig2). The median hyperdiploid fractions for the second (n = 10) and third (n = 8) trimester placentas were 11-8% (5th-95th percentiles = 6 7%-20 7%) and 14 2% (5th-95th percentiles = 13-0%-19 0%), respectively. The overall median hyperdiploid fraction for all diploid placentas was 149% (5th-95th percentiles = 6 8%-22 4%) ( 2) showed a median hyperdiploid fraction of 16 8% (Sth-95th percentiles = 10-1%-26-6%), which is almost completely within the range of placentas but significantly different from that for diploid complete moles (p < 0.0001) and the seven cases of persistent trophoblastic disease (p < 0 001) (fig4). Three of the diploid molar gestations were reclassified as hydropic abortions and showed hyperdiploid fractions of 20 1%, 180%, and 8-8%, falling within the range for placentas.
Triploid molar gestations None of the 26 triploid molar gestations (fig 3) included examples of persistent trophoblastic disease.
Discussion
For histopathologists the distinction between complete moles and partial moles and their differentiation from hydropic abortions is not easy,' especially when there is no access to cytogenetic techniques or the tissue is unsuitable for chromosomal analysis. We have found that the present histological and morphological criteria are not as reliable in practice as has been suggested by other workers. 8 25 Assessment of the degree of villous hydropic swelling and trophoblastic hyperplasia can be highly subjective. Central cistern formation within villi can be seen in both partial moles and complete moles along with trophoblastic "inclu- In addition to the group of diploid partial moles flow cytometry showed one case of partial mole with a DNA tetraploid DNA content and one case each of complete mole and partial mole showing DNA aneuploidy. Occasional cases of tetraploidy have been described in both complete430 and partial moles.3' The importance of DNA aneuploidy in molar pregnancies has not yet been established, although it is a recognised occurrence. 5 Flow cytometric analysis of two of the molar gestations histologically classified as complete mole showed them to be triploid. It is possible that inadequate sampling of the molar tissue resulted in histopathological misdiagnosis. The possible entity of a triploid complete mole of androgenetic origin cannot be completely excluded, however, until further studies have been performed.
In conclusion, we believe that flow cytometric analysis of DNA content has certain advantages over current cytogenetic techniques in that analyses can be 620 Hemming, Quirke, Womack, Wells, Elston, Bird performed rapidly on formalin fixed, paraffin embedded tissues23 either retrospectively or at the time of receipt. The versatility of the technique is emphasised by the clear definition of the different groups obtained even with the relatively high mean CV of 9% in this series. The results of this study show that the flow cytometric measurements of DNA content may be an important aid in the accurate diagnosis of molar gestations since the ploidy status for a given specimen can be rapidly determined along with the hyperdiploid fraction in diploid cases. The use of the flow cytometer in the identification of those patients at risk of developing persistent trophoblastic disease needs to be studied further. In our series the seven cases of clinically confirmed persistent trophoblastic disease were diploid and showed hyperdiploid fractions characteristic of a complete diploid mole. As a research tool flow cytometric measurement of DNA content should provide further insight into the origins and, more importantly, the risk of persistent trophoblastic disease for each subtype of hydatidiform mole.
